Kristin Agopian, PhD

Senior Licensing Officer
Office of Technology Management
+1 415 340-2619

Kristin has been managing intellectual property and commercialization for UCSF since 2008. Her portfolio of technologies includes therapeutics, diagnostics, and medical devices.  She works closely with UCSF faculty and staff to develop and commercialize their inventions, build large research collaboration and licensing partnerships, and spin out companies.  In addition, she negotiates and drafts IP agreements including licenses, options, inter-institutional agreements, CDAs and MTAs.

Kristin holds a Ph.D. in Virology from Harvard University and an A.B. in Molecular Biology from Princeton University. She has hands-on research experience in HIV pathogenesis, cell signaling, cell biology, mouse genetics and Drosophila development and speciation.  She also has experience in business strategy consulting in the biotechnology and pharmaceutical space and in science & technology policy at the National Academies.

Publications: 

Evidence for adaptive evolution at the divergence between lymphoid and brain HIV-1 nef genes.

AIDS research and human retroviruses

Olivieri KC, Agopian KA, Mukerji J, Gabuzda D

Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.

Virology

Gorry PR, Dunfee RL, Mefford ME, Kunstman K, Morgan T, Moore JP, Mascola JR, Agopian K, Holm GH, Mehle A, Taylor J, Farzan M, Wang H, Ellery P, Willey SJ, Clapham PR, Wolinsky SM, Crowe SM, Gabuzda D